Latest Innovation News

Audeara Limited has secured a $1.22 million R&D tax incentive refund for FY25, strengthening its financial position by repaying debt and retaining non-dilutive funding to fuel ongoing product development.

CSIRO has sold about half its shares in Chrysos Corporation through a block trade, reducing its stake by roughly 9%, yet remains a committed substantial shareholder with a six-month escrow on its retained shares.

Straker Ltd’s H1 FY26 results reveal a strategic shift from legacy translation services to AI-driven specialised language models, anchored by a $28 million partnership with IBM. Despite a 15% revenue decline, the company maintains positive adjusted EBITDA and a strong balance sheet.

Straker Ltd reports a solid first half of FY26 with positive EBITDA and a renewed IBM partnership, despite a 15% revenue decline amid challenging market conditions.

Temple & Webster Group delivered a robust FY25 with 21% revenue growth and expanded into New Zealand, reaffirming its ambitious growth and profitability targets for FY26.

Cleo Diagnostics has secured a $1.7 million R&D tax refund, strengthening its cash reserves to $5.75 million as it advances toward a pivotal US clinical trial and FDA submission for its ovarian cancer test.

HyTerra Limited has partnered with GeoKiln Energy Innovation to pioneer a groundbreaking test of engineered geologic hydrogen production, aiming to accelerate commercialization in this emerging energy sector.

Parkway Corporate Limited has marked its transition to profitability in FY25, unveiling a transformative Queensland Brine Management Complex project set to redefine waste brine processing in Australia’s coal seam gas sector.

Genesis Energy’s 2025 Investor Day confirms its strategy and earnings growth remain firmly on track, anchored by a substantial renewable pipeline and robust capital management.

Fisher & Paykel Healthcare reported a robust 14% revenue increase and a 39% jump in net profit for the first half of fiscal 2026, driven by strong clinical adoption and product innovation.

Osteopore Limited has drawn an additional A$250,000 under the first tranche of its redeemable convertible notes, continuing its steady capital raise to support growth and innovation.

Locate Technologies has successfully raised NZ$1 million to bolster its balance sheet ahead of its planned listing on the New Zealand Exchange this December. The capital raise reflects strong investor confidence as the company prepares to transition its logistics technology platform to a new market.